BRPI0410093B8 - curativo do tipo de proteção contra ultravioleta - Google Patents

curativo do tipo de proteção contra ultravioleta

Info

Publication number
BRPI0410093B8
BRPI0410093B8 BRPI0410093A BRPI0410093A BRPI0410093B8 BR PI0410093 B8 BRPI0410093 B8 BR PI0410093B8 BR PI0410093 A BRPI0410093 A BR PI0410093A BR PI0410093 A BRPI0410093 A BR PI0410093A BR PI0410093 B8 BRPI0410093 B8 BR PI0410093B8
Authority
BR
Brazil
Prior art keywords
substrate
protection type
dressing
type dressing
photodecompose
Prior art date
Application number
BRPI0410093A
Other languages
English (en)
Inventor
Tsuruda Kiyomi
Takada Yasunori
Hashimoto Yoshiaki
Original Assignee
Hisamitsu Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hisamitsu Pharmaceutical Co filed Critical Hisamitsu Pharmaceutical Co
Publication of BRPI0410093A publication Critical patent/BRPI0410093A/pt
Publication of BRPI0410093B1 publication Critical patent/BRPI0410093B1/pt
Publication of BRPI0410093B8 publication Critical patent/BRPI0410093B8/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7007Drug-containing films, membranes or sheets
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/192Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7076Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising ingredients of undetermined constitution or reaction products thereof, e.g. rosin or other plant resins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00Preparations for use in therapy
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Botany (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

"curativo do tipo de proteção contra ultravioleta". com o fim de prover curativos que não provocam a fotodecomposição de drogas quando expostas aos raios diretos do sol e que demonstram efeitos de droga satisfatórios e são excelentes nas propriedades físicas e estabilidade das preparações farmacêuticas, a invenção provê um curativo compreendendo um substrato de poliéster e uma camada adesiva sensível à pressão formada sobre uma superfície do substrato e contendo uma droga antiinflamatória não esteroidal (nsaid) em que o substrato contém um derivado de hidroxifenilbenzotriazol representado pela fórmula geral (1): em que r~ 1~ e r~ 2~ são cada independentemente hidrogênio ou c~ 1-8~ alquila; e x é átomo de halogênio.
BRPI0410093A 2003-05-07 2004-05-07 curativo do tipo de proteção contra ultravioleta BRPI0410093B8 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2003128934 2003-05-07
JP2003-128934 2003-05-07
PCT/JP2004/006024 WO2004098575A1 (ja) 2003-05-07 2004-05-07 紫外線遮蔽性貼付剤

Publications (3)

Publication Number Publication Date
BRPI0410093A BRPI0410093A (pt) 2006-05-16
BRPI0410093B1 BRPI0410093B1 (pt) 2018-02-14
BRPI0410093B8 true BRPI0410093B8 (pt) 2021-07-27

Family

ID=33432062

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0410093A BRPI0410093B8 (pt) 2003-05-07 2004-05-07 curativo do tipo de proteção contra ultravioleta

Country Status (14)

Country Link
US (1) US20060198880A1 (pt)
EP (1) EP1621188B1 (pt)
JP (1) JP4927403B2 (pt)
KR (1) KR101066192B1 (pt)
CN (1) CN100366240C (pt)
AU (1) AU2004236606B2 (pt)
BR (1) BRPI0410093B8 (pt)
CA (1) CA2524891C (pt)
ES (1) ES2426168T3 (pt)
HK (1) HK1087634A1 (pt)
PL (1) PL1621188T3 (pt)
PT (1) PT1621188E (pt)
TW (1) TWI327074B (pt)
WO (1) WO2004098575A1 (pt)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1872796T3 (da) * 2005-02-25 2011-10-17 Hisamitsu Pharmaceutical Co Transdermal præparat til udvendig brug med et non-steroid antiinflammatorisk/analgetisk middel
US20060263420A1 (en) * 2005-03-10 2006-11-23 Hisamitsu Pharmaceutical Co., Inc. Adhesive and plaster
JP4974535B2 (ja) * 2006-02-02 2012-07-11 久光製薬株式会社 外用製剤及びその製造方法
MY149142A (en) 2006-08-04 2013-07-15 Hisamitsu Pharmaceutical Co Adhesive preparation
WO2009041121A1 (ja) * 2007-09-28 2009-04-02 Yugen Kaisha Kazki Reiko 化粧補助貼付材及び該貼付材を用いた化粧方法
CA2713946C (en) 2008-01-31 2015-12-15 Tomomi Okada Adhesive patch
JP6533639B2 (ja) * 2012-03-16 2019-06-19 株式会社コーセー 皮膚外用剤及び紫外線によるカロテノイド含有油性成分の分解抑制方法
WO2015129808A1 (ja) 2014-02-27 2015-09-03 久光製薬株式会社 ケトプロフェン含有パップ剤
US20220257915A1 (en) * 2021-02-17 2022-08-18 Katy Hamilton Skin Protection Device

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60155111A (ja) * 1983-10-20 1985-08-15 Hisamitsu Pharmaceut Co Inc 安定なケトプロフェン含有外用経皮製剤
AU676562B2 (en) * 1993-05-19 1997-03-13 Hisamitsu Pharmaceutical Co., Inc. Solubilizing agent and external preparation containing the same
JPH0853354A (ja) * 1994-08-11 1996-02-27 Hisamitsu Pharmaceut Co Inc 皮膚疾患用水性貼付剤
DE69524614T2 (de) * 1994-10-05 2002-09-12 Hisamitsu Pharmaceutical Co Arzneimittelbestandteile einschliesslich eines n-substituierten o-toluidinderivats und transdermal absorbierbare zubereitung
JPH08133964A (ja) * 1994-11-05 1996-05-28 Nichiban Co Ltd 有害紫外線吸収性粘着シート
JP3499247B2 (ja) * 1996-12-06 2004-02-23 久光製薬株式会社 フェルビナク含有貼付剤
JP3682465B2 (ja) * 1999-03-31 2005-08-10 独立行政法人産業技術総合研究所 樹脂成形物表面層の改質方法およびそのための装置および表面層が改質された樹脂成形物、および樹脂成形物表面層の着色方法およびそのための装置および表面層が着色された樹脂成形物、および表面層の改質により機能性を付与された樹脂成形物
CA2379147C (en) * 1999-07-15 2009-09-01 Hisamitsu Pharmaceutical Co., Inc. Percutaneously absorbable preparations
JP4584381B2 (ja) * 1999-07-30 2010-11-17 久光製薬株式会社 フェルビナク含有貼付剤
ATE353636T1 (de) * 1999-12-15 2007-03-15 Hisamitsu Pharmaceutical Co Adhäsive zubereitungen
EP1269999B1 (en) * 2000-03-17 2013-05-01 Hisamitsu Pharmaceutical Co. Inc. Ultraviolet-shielding patch
DK1277466T3 (da) * 2000-04-18 2011-10-17 Hisamitsu Pharmaceutical Co Plaster indeholdende et antiinflammatorisk middel
JP4192411B2 (ja) * 2000-07-12 2008-12-10 コニカミノルタホールディングス株式会社 偏光板用保護フィルム
US6624410B1 (en) * 2002-02-25 2003-09-23 Monitor Instruments Company, Llc Cycloidal mass spectrometer

Also Published As

Publication number Publication date
EP1621188A1 (en) 2006-02-01
US20060198880A1 (en) 2006-09-07
CN1784219A (zh) 2006-06-07
PL1621188T3 (pl) 2013-12-31
CN100366240C (zh) 2008-02-06
BRPI0410093B1 (pt) 2018-02-14
WO2004098575A1 (ja) 2004-11-18
CA2524891C (en) 2014-07-08
EP1621188B1 (en) 2013-07-10
CA2524891A1 (en) 2004-11-18
PT1621188E (pt) 2013-09-26
AU2004236606A1 (en) 2004-11-18
TW200510007A (en) 2005-03-16
TWI327074B (en) 2010-07-11
JPWO2004098575A1 (ja) 2006-07-13
JP4927403B2 (ja) 2012-05-09
KR101066192B1 (ko) 2011-09-21
HK1087634A1 (en) 2006-10-20
BRPI0410093A (pt) 2006-05-16
KR20060007420A (ko) 2006-01-24
EP1621188A4 (en) 2012-01-25
AU2004236606B2 (en) 2010-03-11
ES2426168T3 (es) 2013-10-21

Similar Documents

Publication Publication Date Title
BRPI0211993B8 (pt) sistema terapêutico transdermal à base de adesivos de poliacrilato sem grupos funcionais
BRPI0407882A (pt) conjugados de polìmero-porção de fator viii
BRPI0410093B8 (pt) curativo do tipo de proteção contra ultravioleta
AR007418A1 (es) Composicion adhesiva sensible a la presion
NO20042596L (no) Inbibitorer av 11-beta-hydroksy steroid dehydrogenase type 1
BR0208005A (pt) Preparação para adesivo tópico contendo indutor de hipersensibilidade do tipo retardado e processos para a utilização do mesmo
BR0313949A (pt) Sìlica
DE69923786D1 (de) Dünner polymerfilm als medikamentenreservoir
ECSP088469A (es) Sistema terapeutico transdermico
BR9806470A (pt) Preparação do tipo absorção percutânea.
DE60002249T2 (de) Silikonzusammensetzung und Silikonhaftklebstoff
PT1011552E (pt) Dilatador nasal medicamentado de montagem externa
DK1007597T3 (da) Absorberende trykfølsomme klæbere til biologiske væsker
BR0001001A (pt) Composição, e, processo de proteger forração de gesso
ATE542871T1 (de) Schutzfolien und druckempfindliche haftmittel
HRP20050828B1 (hr) Uv-stabilni transdermalni flaster
AR056754A1 (es) Composiciones para el tratamiento del cabello
AU1800099A (en) Transdermal delivery devices containing polydiorganosiloxane polymers to regulate adhesive properties
FR2825097B1 (fr) Compositions adhesives et films de protection de surfaces en contenant
BRPI0408457B8 (pt) emplastro adesivo contendo agente antiinflamatório não-esteroidal
ATE297717T1 (de) Heparin und diclofenac enthaltendes topisches pflaster
DE69829322D1 (de) Druckempfindliche Klebefolie für Oberflächenschutz, und druckempfindliche Klebstoffzusammensetzung für Oberflächenschutz
BR0109893A (pt) Preparação farmacêutica de lerisetron na forma de um sistema terapêutico transdêrmico, uso da preparação, uso da substância ativa lerisetron e método para administrar a substância ativa lerisetron a um paciente
BR0209063A (pt) Medicamentos e kits de uso medicinal
BR0008192A (pt) Emplastros tipo folha

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07G Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]
B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 07/05/2004, OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF, QUE DETERMINA A ALTERACAO DO PRAZO DE CONCESSAO